Jaguar Land Rover is facing parts shortages and will suspend the production of Land Rover Discovery, Evoque, Velar, and Jaguar XE, XF, F-Pace, and I-Pace in September.
Production will continue with the Jaguar F-Type, Range Rover, Range Rover Sport and Defender.
The I-Pace assembled by Magna International in Graz, Austria, is its only fully electric model, and production will stop while demand for electric cars is surging.
As petrol engines are phased out by 2025, Jaguar hinted that it will develop its more upscale BEV with a contractor rather than in the Midlands.
The next pure-electric Land Rover vehicles are expected to arrive in the second part of this decade, with a smaller electric Jaguar model possibly produced in the UK.
A variant of the internally developed Magna platform, which is shared with US EV company Fisker, is expected to be used as JLR was unable to adapt the LR and RR electric vehicle platform for its larger Jaguar model.


Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
How to support someone who is grieving: five research-backed strategies
What’s the difference between baking powder and baking soda? It’s subtle, but significant
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Locked up then locked out: how NZ’s bank rules make life for ex-prisoners even harder
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



